Phase I/II study of S-1 combined with biweekly irinotecan chemotherapy in previously treated advanced non-small cell lung cancer

被引：0
|
作者：
Hiroki Goya
Hiroshi Kuraishi
Shigeru Koyama
Takashi Ichiyama
Fumiaki Yoshiike
Kazuya Hirai
Toshihiko Agatsuma
Kazunari Tateishi
Shintaro Kanda
Hiroshi Yamamoto
Keishi Kubo
Tomonobu Koizumi
机构：
[1] Nagano Red Cross Hospital,Respiratory Division
[2] Nagano Municipal Hospital,Respiratory Division
[3] Shinshu University School of Medicine,First Department of Internal Medicine
[4] Shinshu University Hospital School of Medicine,Division of Clinical Oncology, Comprehensive Cancer Center
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 70卷
关键词：
Chemo-refractory; Salvage chemotherapy; Second line; CTP-11;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：691 / 697
页数：6
相关论文
共 50 条
  • [1] Phase I/II study of S-1 combined with biweekly irinotecan chemotherapy in previously treated advanced non-small cell lung cancer
    Goya, Hiroki
    Kuraishi, Hiroshi
    Koyama, Shigeru
    Ichiyama, Takashi
    Yoshiike, Fumiaki
    Hirai, Kazuya
    Agatsuma, Toshihiko
    Tateishi, Kazunari
    Kanda, Shintaro
    Yamamoto, Hiroshi
    Kubo, Keishi
    Koizumi, Tomonobu
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (05) : 691 - 697
  • [2] A Phase II study of S-1 and irinotecan combination therapy in previously treated patients with advanced non-small cell lung cancer
    Ikemura, Shinnosuke
    Naoki, Katsuhiko
    Yasuda, Hiroyuki
    Kawada, Ichiro
    Yoda, Satoshi
    Terai, Hideki
    Sato, Takashi
    Ishioka, Kota
    Arai, Daisuke
    Ohgino, Keiko
    Kamata, Hirofumi
    Miyata, Jun
    Kabata, Hiroki
    Betsuyaku, Tomoko
    Soejima, Kenzo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (04) : 356 - 361
  • [3] A phase I study of S-1 and irinotecan combination therapy in previously treated advanced non-small cell lung cancer patients
    Yoda, Satoshi
    Soejima, Kenzo
    Yasuda, Hiroyuki
    Naoki, Katsuhiko
    Kawada, Ichiro
    Watanabe, Hideo
    Nakachi, Ichiro
    Satomi, Ryosuke
    Nakayama, Sohei
    Ikemura, Sinnosuke
    Terai, Hideki
    Sato, Takashi
    Morosawa, Maiko
    Asano, Koichiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (03) : 717 - 722
  • [4] A phase I study of S-1 and irinotecan combination therapy in previously treated advanced non-small cell lung cancer patients
    Satoshi Yoda
    Kenzo Soejima
    Hiroyuki Yasuda
    Katsuhiko Naoki
    Ichiro Kawada
    Hideo Watanabe
    Ichiro Nakachi
    Ryosuke Satomi
    Sohei Nakayama
    Sinnosuke Ikemura
    Hideki Terai
    Takashi Sato
    Maiko Morosawa
    Koichiro Asano
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 717 - 722
  • [5] Phase I/II study of docetaxel and S-1 in patients with previously treated non-small cell lung cancer
    Atagi, Shinji
    Kawahara, Masaaki
    Kusunoki, Yoko
    Takada, Minoru
    Kawaguchi, Tomoya
    Okishio, Kyoiti
    Kubo, Akihito
    Uehira, Kazutaka
    Yumine, Katsuyuki
    Tomizawa, Yoshio
    Saito, Ryusei
    Fukai, Shimao
    Komatsu, Hikotaro
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (09) : 1012 - 1017
  • [6] Phase I study of daily S-1 combined with weekly irinotecan in patients with advanced non-small cell lung cancer
    Osamu Ishimoto
    Takashi Ishida
    Yoshihiro Honda
    Mitsuru Munakata
    Shunichi Sugawara
    International Journal of Clinical Oncology, 2009, 14 : 43 - 47
  • [7] Phase I study of daily S-1 combined with weekly irinotecan in patients with advanced non-small cell lung cancer
    Ishimoto, Osamu
    Ishida, Takashi
    Honda, Yoshihiro
    Munakata, Mitsuru
    Sugawara, Shunichi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (01) : 43 - 47
  • [8] Phase II study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancer
    Kazuhiro Yanagihara
    Kenichi Yoshimura
    Miyuki Niimi
    Hiroyasu Yasuda
    Takahiko Sasaki
    Takafumi Nishimura
    Hiroshi Ishiguro
    Shigemi Matsumoto
    Toshiyuki Kitano
    Masashi Kanai
    Akiko Misawa
    Harue Tada
    Satoshi Teramukai
    Tadashi Mio
    Masanori Fukushima
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 913 - 918
  • [9] Phase II study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancer
    Yanagihara, Kazuhiro
    Yoshimura, Kenichi
    Niimi, Miyuki
    Yasuda, Hiroyasu
    Sasaki, Takahiko
    Nishimura, Takafumi
    Ishiguro, Hiroshi
    Matsumoto, Shigemi
    Kitano, Toshiyuki
    Kanai, Masashi
    Misawa, Akiko
    Tada, Harue
    Teramukai, Satoshi
    Mio, Tadashi
    Fukushima, Masanori
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (05) : 913 - 918
  • [10] PHASE II STUDY OF BIWEEKLY IRINOTECAN PLUS BEVACIZUMAB IN HEAVILY TREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Cardona, Andres F.
    Arrieta, Oscar
    Cuello, Mauricio
    Corrales, Luis
    Vargas, Carlos
    Martin, Claudio
    Carranza, Hernan
    Otero, Jorge M.
    Katherine Rodriguez, July
    Mas, Luis
    Archila, Pilar
    Bramuglia, Guillermo
    Pastran, Zulay
    Curcio, Elizabeth
    Rojas, Leonardo
    Bernal, Laura
    Campos Parra, Alma D.
    Giannikopoulos, Petros
    Rosell, Rafael
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S881 - S882
12345